Commentary: Treatment failure and success: a commentary on defining and treating pediatric treatment‐resistant depression – reflections on Dwyer et al. (2020)

Nearly two in five youth with major depressive disorder fail to respond to first‐line interventions. As such, treatment‐resistant depression represents a formidable challenge for clinicians and researchers. In fact, even considering the diagnosis of treatment‐resistant depression in children and ado...

Full description

Saved in:
Bibliographic Details
Published inJournal of child psychology and psychiatry Vol. 61; no. 3; pp. 333 - 335
Main Authors Strawn, Jeffrey R., Croarkin, Paul E.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.03.2020
John Wiley and Sons Inc
Subjects
Adolescent
Adult
Annual Research Reviews
Child
Child & adolescent psychiatry
Depression
Depressive Disorder, Major
Depressive personality disorders
Humans
Intervention
major depressive disorder
Medical diagnosis
Mental depression
Neuromodulation
Psychotherapy
Research Personnel
Treatment Failure
treatment‐resistant depression
major depressive disorder
treatment-resistant depression
Depression
Online AccessGet full text

Cover

More Information
Summary:Nearly two in five youth with major depressive disorder fail to respond to first‐line interventions. As such, treatment‐resistant depression represents a formidable challenge for clinicians and researchers. In fact, even considering the diagnosis of treatment‐resistant depression in children and adolescents requires (a) defining treatment‐resistant depression and, by extension, treatment failure; (b) defining recovery; (c) understanding its developmental trajectory; and in addition to (d) understanding the evidence for treatment interventions in this population. Accumulating data suggest that treatment‐resistant depression is heterogeneous and that this heterogeneity may inform interventions. Additionally, these data suggest that substantially more nuance is needed in evaluating the ‘adequacy’ of prior treatments whether they are psychotherapeutic or psychopharmacologic. Last, adjunctive interventions that focus on neuromodulation, glutamatergic, GABAergic, and inflammatory pathways remain poorly understood in youth with treatment‐resistant depression despite very significant advances in adults with treatment‐resistant depression. Read the full article at doi: 10.1111/jcpp.13202
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
Conflict of interest statement: See Acknowledgements for full disclosures.
Read the full article at doi: 10.1111/jcpp.13202
ISSN:0021-9630
1469-7610
DOI:10.1111/jcpp.13207